Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.

Land S, Zhou J, Cunningham P, Sohn AH, Singtoroj T, Katzenstein D, Mann M, Sayer D, Kantor R.

J Int AIDS Soc. 2013 Jul 10;16:18580. doi: 10.7448/IAS.16.1.18580.

PMID:
23845227
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories.

Land S, Cunningham P, Zhou J, Frost K, Katzenstein D, Kantor R, Chen YM, Oka S, DeLong A, Sayer D, Smith J, Dax EM, Law M; TAQAS Laboratory Network.

J Virol Methods. 2009 Aug;159(2):185-93. doi: 10.1016/j.jviromet.2009.03.016. Epub 2009 Mar 26.

PMID:
19490972
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 Genotyping Proficiency Programme.

Pandit A, Mackay WG, Steel C, van Loon AM, Schuurman R.

J Clin Virol. 2008 Dec;43(4):401-6. doi: 10.1016/j.jcv.2008.08.021. Epub 2008 Nov 1. Review.

PMID:
18977690
[PubMed - indexed for MEDLINE]
4.

Evaluation of an affordable HIV-1 virological failure assay and antiretroviral drug resistance genotyping protocol.

Bronze M, Aitken SC, Wallis CL, Steegen K, Stuyver LJ, de Wit TF, Stevens W.

J Virol Methods. 2013 Dec;194(1-2):300-7. doi: 10.1016/j.jviromet.2013.08.015. Epub 2013 Aug 28.

PMID:
23994150
[PubMed - indexed for MEDLINE]
5.

Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010.

Parkin N, Bremer J, Bertagnolio S.

Clin Infect Dis. 2012 May;54 Suppl 4:S266-72. doi: 10.1093/cid/cir992.

PMID:
22544186
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LX, Chaix ML, Delaporte E, Ayouba A, Peeters M; ANRS 12235 Study Group.

J Clin Microbiol. 2014 Feb;52(2):578-86. doi: 10.1128/JCM.02860-13. Epub 2013 Dec 11.

PMID:
24478491
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.

Bertagnolio S, Derdelinckx I, Parker M, Fitzgibbon J, Fleury H, Peeters M, Schuurman R, Pillay D, Morris L, Tanuri A, Gershy-Damet GM, Nkengasong J, Gilks CF, Sutherland D, Sandstrom P.

Antivir Ther. 2008;13 Suppl 2:49-57.

PMID:
18575191
[PubMed - indexed for MEDLINE]
8.

Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.

Chen JH, Wong KH, Chan K, Lam HY, Lee SS, Li P, Lee MP, Tsang DN, Zheng BJ, Yuen KY, Yam WC.

J Clin Virol. 2007 Jun;39(2):125-31. Epub 2007 Apr 20.

PMID:
17449318
[PubMed - indexed for MEDLINE]
9.

Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypes.

Aitken SC, Kliphuis A, Wallis CL, Chu ML, Fillekes Q, Barth R, Stevens W, Rinke de Wit TF, Schuurman R.

J Clin Virol. 2012 May;54(1):21-5. doi: 10.1016/j.jcv.2012.01.010. Epub 2012 Feb 3.

PMID:
22306272
[PubMed - indexed for MEDLINE]
10.

Improvement of the oligonucleotide ligation assay for detection of the M184V drug-resistant mutation in patients infected with human immunodeficiency virus type 1 subtype CRF01_AE.

Dokuta S, Utaipat U, Praparattanapan J, Keitkarn J, Maneekarn N, Sirisanthana T, Supparatpinyo K.

J Virol Methods. 2013 Jun;190(1-2):20-8. doi: 10.1016/j.jviromet.2013.03.016. Epub 2013 Apr 3.

PMID:
23562659
[PubMed - indexed for MEDLINE]
11.

Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.

Parisi SG, Boldrin C, Cruciani M, Nicolini G, Cerbaro I, Manfrin V, Dal Bello F, Franchin E, Franzetti M, Rossi MC, Cattelan AM, Romano L, Zazzi M, Andreoni M, Palù G.

J Clin Microbiol. 2007 Jun;45(6):1783-8. Epub 2007 Apr 18. Erratum in: J Clin Microbiol. 2007 Oct;45(10):3484.

PMID:
17442799
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit.

Stelzl E, Pröll J, Bizon B, Niklas N, Danzer M, Hackl C, Stabentheiner S, Gabriel C, Kessler HH.

J Virol Methods. 2011 Dec;178(1-2):94-7. doi: 10.1016/j.jviromet.2011.08.020. Epub 2011 Aug 27.

PMID:
21907239
[PubMed - indexed for MEDLINE]
13.

Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer.

Eshleman SH, Crutcher G, Petrauskene O, Kunstman K, Cunningham SP, Trevino C, Davis C, Kennedy J, Fairman J, Foley B, Kop J.

J Clin Microbiol. 2005 Feb;43(2):813-7.

PMID:
15695685
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan.

Fujisaki S, Fujisaki S, Ibe S, Asagi T, Itoh T, Yoshida S, Koike T, Oie M, Konda M, Sadamasu K, Nagashima M, Gatanaga H, Matsuda M, Ueda M, Masakane A, Hata M, Mizogami Y, Mori H, Minami R, Okada K, Watanabe K, Shirasaka T, Oka S, Sugiura W, Kaneda T.

Jpn J Infect Dis. 2007 May;60(2-3):113-7.

PMID:
17515643
[PubMed - indexed for MEDLINE]
Free Article
15.

Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey.

Bussmann H, de la Hoz Gomez F, Roels TH, Wester CW, Bodika SM, Moyo S, Taffa N, Anderson MG, Mine M, Bile EC, Yang C, Mphoyakgosi K, Lehotzky EA, Mlotshwa B, Mmelesi M, Seipone K, Makhema MJ, Marlink RG, Novitsky V, Essex M.

AIDS Res Hum Retroviruses. 2011 Apr;27(4):365-72. doi: 10.1089/aid.2010.0273. Epub 2010 Oct 29.

PMID:
21034246
[PubMed - indexed for MEDLINE]
16.

HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.

Nguyen HT, Duc NB, Shrivastava R, Tran TH, Nguyen TA, Thang PH, McNicholl JM, Leelawiwat W, Chonwattana W, Sidibe K, Fujita M, Luu CM, Kakkar R, Bennett DE, Kaplan J, Cosimi L, Wolfe MI.

Antivir Ther. 2008;13 Suppl 2:115-21.

PMID:
18575200
[PubMed - indexed for MEDLINE]
17.

Results of the 2001 AcroMetrix HIV-1 resistance proficiency program.

Neuwald PD, Funelas MB, DelCarmen JP, Raybold AW, Jorgensen PA.

J Clin Virol. 2002 Dec;25 Suppl 3:S55-63.

PMID:
12467778
[PubMed - indexed for MEDLINE]
18.

Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.

Chew KK, Ng KY, Khong WX, Kaur P, Yap JK, Chua A, Tan MT, Koh YL, Thoon KC, Leo YS, Ng OT.

Ann Acad Med Singapore. 2012 Dec;41(12):553-8.

PMID:
23303111
[PubMed - indexed for MEDLINE]
Free Article
19.

Would CLSI M53-A have helped in the diagnosis of HIV in Canada? Results of the performance of Canadian laboratories participating in a recent NLHRS proficiency testing panel containing HIV-1 antigen positive (antibody negative) and HIV-2 samples.

Kadivar K, Malloch L, Adonsou-Hoyi Y, Ng D, Lavoie S, Pulido K, Kim J.

J Clin Virol. 2013 Sep;58(1):303-5. doi: 10.1016/j.jcv.2013.04.009. Epub 2013 Jul 26.

PMID:
23890809
[PubMed - indexed for MEDLINE]
Free Article
20.

Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance.

Galli RA, Sattha B, Wynhoven B, O'Shaughnessy MV, Harrigan PR.

J Clin Microbiol. 2003 Jul;41(7):2900-7.

PMID:
12843019
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk